Impact of Aging on Mucosal Immune Protection in the Female Reproductive

衰老对女性生殖粘膜免疫保护的影响

基本信息

  • 批准号:
    10547801
  • 负责人:
  • 金额:
    $ 46.56万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-03-01 至 2024-12-31
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract An urgent need exists to understand the impact of aging on mucosal immunity in the female reproductive tract (FRT) of postmenopausal women, given the increased risk of infections and the lack of knowledge of immune alterations that occur as women age. Recognizing that menopause and the accompanying absence of sex hormones fundamentally alters the immune environment in the FRT, the overall goal of this proposal is to arrive at a mechanistic understanding of how aging (50-59, 60-69 and >70yrs) impacts pathogen recognition, immune protection and induction of immune responses in the upper and lower FRT. This proposal has 3 original Aims: 1) Determine the extent to which aging compromises immune protection by FRT epithelial cells. As epithelial cells are the first line of defense against pathogens, we will identify the extent to which pattern recognition receptor (PRR) signaling by epithelial cells is compromised with aging. We will also determine age- dependent changes in secreted innate molecules with antimicrobial and chemotaxis capacity. 2) Determine the impact of aging on local immune protection by evaluating resident and non-resident T cell function throughout the FRT. In this Aim, we will evaluate age-dependent changes in cytotoxic activity and secreted immune responses (antimicrobials and cytokines) following activation of CD4+ and CD8+ tissue resident and non-resident T cells throughout the FRT. 3) Determine the impact of aging on dendritic cell (DC) pathogen recognition and induction of T cell responses throughout the FRT. This aim will identify age-associated changes in PRR responses by DCs and in DC's ability to induce T cell responses, as well as the mechanisms that control DC function as women age. This study is unique in that it integrates aging with our understanding of the innate and adaptive mucosal immune system throughout the human FRT, as it relates directly to mucosal protection by the very cells most likely to interact and respond to pathogens. These studies will provide much needed information that is essential to identify age-related changes in immune function in the FRT and influence responses to urinary tract infections (UTIs) and sexually-transmitted infections (STIs). As older women are generally excluded from prevention research for STIs, and vaccination recommendations (for example HPV), our studies will provide a foundation to define mucosal immune protection in elderly women and develop appropriate strategies for the prevention of new infections and pathogen reactivation.
项目摘要/摘要 迫切需要了解衰老对女性生殖道粘膜免疫的影响 (FRT)绝经后妇女,鉴于感染风险增加和缺乏免疫知识 随着女性年龄的增长而发生的变化。认识到更年期和随之而来的性生活缺失 激素从根本上改变了FRT中的免疫环境,这项提议的总体目标是 对衰老(50-59岁、60-69岁和70岁)如何影响病原体识别、免疫 保护和诱导上、下FRT中的免疫反应。这项提议最初有三个目标: 1)确定衰老对FRT上皮细胞免疫保护的影响程度。AS 上皮细胞是抵御病原体的第一道防线,我们将在多大程度上识别这种模式 上皮细胞的识别受体(PRR)信号随着年龄的增长而受损。我们还将确定年龄- 分泌的具有抗菌和趋化能力的先天分子的依赖性变化。 2)通过评估居民和非居民来确定老龄化对局部免疫保护的影响 T细胞在FRT的整个过程中发挥作用。在这个目标中,我们将评估细胞毒活性随年龄的变化。 以及在激活CD4+和CD8+组织后分泌的免疫反应(抗菌素和细胞因子) FRT中的常驻和非常驻T细胞。 3)确定衰老对树突状细胞(DC)病原体识别和T细胞诱导的影响 在整个FRT过程中都有反应。这一目标将确定DC在PRR反应中的年龄相关变化,并 DC诱导T细胞反应的能力,以及控制DC功能的机制随着女性年龄的增长而变化。 这项研究的独特之处在于,它将衰老与我们对天然和适应性粘膜免疫的理解结合在一起。 整个人类FRT系统,因为它直接与粘膜保护有关,正是这种细胞最有可能 相互作用并对病原体做出反应。这些研究将提供急需的信息,这些信息对于 确定FRT中与年龄相关的免疫功能变化,并影响对尿路感染的反应 (性传播感染)和性传播感染(性传播感染)。因为老年妇女通常被排除在预防之外 性传播感染的研究和疫苗接种建议(例如HPV),我们的研究将提供基础 明确老年妇女的黏膜免疫保护,并制定适当的预防策略 新的感染和病原体重新激活。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Charles Robert Wira其他文献

Charles Robert Wira的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Charles Robert Wira', 18)}}的其他基金

Impact of Aging on Mucosal Immune Protection in the Female Reproductive
衰老对女性生殖粘膜免疫保护的影响
  • 批准号:
    10371024
  • 财政年份:
    2019
  • 资助金额:
    $ 46.56万
  • 项目类别:
Impact of Aging on Mucosal Immune Protection in the Female Reproductive
衰老对女性生殖粘膜免疫保护的影响
  • 批准号:
    10613053
  • 财政年份:
    2019
  • 资助金额:
    $ 46.56万
  • 项目类别:
Chemical Contraceptive Control of Microbicides in the Female Reproductive Tract
化学避孕药对女性生殖道杀菌剂的控制
  • 批准号:
    9210054
  • 财政年份:
    2015
  • 资助金额:
    $ 46.56万
  • 项目类别:
Regulation of the Reproductive Tract Environment and Prevention of HIV Infection
生殖道环境的调节与HIV感染的预防
  • 批准号:
    8541405
  • 财政年份:
    2013
  • 资助金额:
    $ 46.56万
  • 项目类别:
Menstrual Cycle Control of HIV Infection in the Reproductive Tract
月经周期控制生殖道艾滋病毒感染
  • 批准号:
    8624656
  • 财政年份:
    2012
  • 资助金额:
    $ 46.56万
  • 项目类别:
Menstrual Cycle Control of HIV Infection in the Reproductive Tract
月经周期控制生殖道艾滋病毒感染
  • 批准号:
    8458046
  • 财政年份:
    2012
  • 资助金额:
    $ 46.56万
  • 项目类别:
Menstrual Cycle Control of HIV Infection in the Reproductive Tract
月经周期控制生殖道艾滋病毒感染
  • 批准号:
    8317878
  • 财政年份:
    2012
  • 资助金额:
    $ 46.56万
  • 项目类别:
Innate Immune Protection Against HIV-1 by Reproductive Tract Epithelial Cells
生殖道上皮细胞针对 HIV-1 的先天免疫保护
  • 批准号:
    7891250
  • 财政年份:
    2007
  • 资助金额:
    $ 46.56万
  • 项目类别:
Innate Immune Protection Against HIV-1 by Reproductive Tract Epithelial Cells
生殖道上皮细胞针对 HIV-1 的先天免疫保护
  • 批准号:
    8856913
  • 财政年份:
    2007
  • 资助金额:
    $ 46.56万
  • 项目类别:
Innate Immune Protection Against HIV-1 by Reproductive Tract Epithelial Cells
生殖道上皮细胞针对 HIV-1 的先天免疫保护
  • 批准号:
    7658772
  • 财政年份:
    2007
  • 资助金额:
    $ 46.56万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 46.56万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.56万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 46.56万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.56万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 46.56万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 46.56万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.56万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 46.56万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 46.56万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 46.56万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了